Dissertation > Excellent graduate degree dissertation topics show

The Side Effect of Zoladex in the Endocrinotherapy of Breast Cancer

Author: ZhangBoChun
Tutor: XuZheLi
School: Jilin University
Course: Surgery
Keywords: breast cancer Zoladex tamoxifen endocrinotherapy
CLC: R737.9
Type: Master's thesis
Year: 2010
Downloads: 87
Quote: 0
Read: Download Dissertation

Abstract


Objective:To research the side effect of Zoladex on the treatment of breast cancer.Methods: The research includes 92 patients who previously accepted breast cancer operation and chemotherapy. 92 patients were divided into 2 groups randomly. Group A: 46 patients treated with Zoladex, subcutaneous injection, 3.6mg, every 28 days. Group B: 46 patients treated with tamoxifen, taken orally, 20mg, every day. Both are used for 2 years. Tomaxifen is a traditional drug to the endocrinotherapy of breast cancer. B group is seen as blank group to evaluate the effect of A group. The data are shown in the form of x±S, and processed with SPSS (statistical package for social science) statistical software. x2 test is performed to get the variation between the two groups. When P<0.05, the difference between two groups is significant.Results:the side effect of patients in group A and that of group B does not have significant difference in statistics(P〉0.05).Conclusion:Zoladex used in pre- and peri- menopausal breast cancer patients is better than tamoxifen on the effect of the treatment of breast cancer, but added side effect is not seen.

Related Dissertations

  1. The Effects of Pu-erh Tea on Prevetion and Treatment of Tumor,R285.5
  2. The Related Study of Breast-conserving Surgery Plus Postoperative Tangential Irradiation,R737.9
  3. The Relevance Research between Breast Cancer Calcification X Performance and Pathology,R737.9
  4. Comparative Analysis on CTF and CEF Regimens as Postoperative Adjuvant Chemotherapy in the Treatment of Phase Ⅱ Breast Cancer,R737.9
  5. The Correlation of Ultrasound Elasticity with the Expressions of Estrogen Receptor, Progestron Receptor, C-erbB-2 in Breast Cancer,R445.1
  6. Expressions of HOXA9 HOXA10 and HOXA11 in Breast Cancer,R737.9
  7. The Feasibility of the Immunohistochemistry Classification to Predicting Prognosis in Breast Cancer,R737.9
  8. The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
  9. Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
  10. The Expression and Significance of Parathyroid Hormone-related Protein in Human Breast Cancer with Skeletal Metastases,R737.9
  11. The Shrink Pattern of Breast Cancer After Neoadjuvant Chemotherapy and the Correlation with Partial Clinic Pathological Factors: Preliminary Results of a Plot Study,R737.9
  12. Analysis of Clinial and Patholgoic Characteristics between the Han and the Uygur Patients with Triple-negative Breast Cancer,R737.9
  13. Clinical Signifinance of Combined Detection of Tumor Markers in Breast Cancer,R737.9
  14. Isoflavone intake and the risk of breast and prostate cancer Meta-analysis,R737.25
  15. Mammographic X-ray analysis of false-negative breast cancer,R737.9
  16. Epidermal growth factor in breast carcinoma and its clinical significance 1,2,R737.9
  17. CK5 / 6 and EGFR as triple negative breast cancer prognostic factors analysis,R737.9
  18. Association of TGFB1 and TGFBR2 Polymorphisms with Breast Cancer Risk,R737.9
  19. Study on the Effect and Mechanism of Tamoxifen on the Radiosensitivity in Glioma Cell SHG44,R737.9
  20. Expression Changes of C-erbB-2, CXCR4 and ER-α after Neoadjuvant Chemotherapy in Breast Cancer and Their Significance,R737.9
  21. The Correlation Study between Pathology Grading and Mental Health in Breast Cancer Patients,R737.9

CLC: > Medicine, health > Oncology > Genitourinary tumors > Breast tumor
© 2012 www.DissertationTopic.Net  Mobile